Scholarly Works
Research Output
Recent Publications
Emerging involvement of CXCL13 in cancer development and progression
Publishing year: 2026
Journal article
Cytokine and Growth Factor Reviews, 2026, Volume 87
Scopus
Pages 73-88
CXCL13, a chemokine originally identified for its role in B-cell trafficking, signals through the G-protein-coupled receptor CXCR5, to organize germinal centers and maintain immune architecture in secondary lymphoid organs. Beyond its physiological functions, accumulating evidence implicates the CXCL13-CXCR5 axis in the reciprocal regulation of inflammation and cancer. In this review, we outline our current understanding of its molecular organization, signaling properties, and regulatory feedback loops that fine-tune receptor activity. We further examine how CXCL13-CXCR5 signaling contributes to aquisition of cancer hallmarks, mainly through angiogenesis, epithelial-mesenchymal transition, metastatic niche conditioning, and the formation of tertiary lymphoid structures that influence antitumor immunity. By integrating biochemical, structural, and immunological insights, this review highlights the CXCL13-CXCR5 axis as a critical interface between lymphoid neogenesis and tumor evolution, and as a potential target for therapeutic modulation in cancer.
A modified α-synuclein seed amplification assay in Lewy body dementia using Raman spectroscopy and machine learning analysis
Publishing year: 2026
Journal article
Journal of Neuroscience Methods, 2026, Volume 425
Scopus
Background Lewy body dementias (LBD), comprising dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD), are defined by misfolded α-synuclein aggregation. Seed amplification assays (SAAs), such as RT-QuIC, enable sensitive detection of α-synuclein aggregates but typically provide binary readouts and require fluorescence labeling. Raman spectroscopy offers a label-free approach to detect subtle biochemical changes, and its diagnostic potential can be enhanced with machine learning. Objectives This proof-of-concept study aimed to evaluate whether Raman spectroscopy combined with machine learning can improve SAA-based discrimination of LBD from controls in cerebrospinal fluid (CSF). Methods We analyzed a small number of post-mortem CSF samples from pathologically confirmed DLB (n = 2), PDD (n = 2), and controls (n = 2) using a 7-day SAA. Raman spectra were collected on Days 1, 4, and 7 and analyzed using principal component analysis (PCA) and uniform manifold approximation and projection (UMAP). Results Following SAA, both PCA and UMAP distinguished combined LBD samples from controls within 24 h (Day 1), reflecting biochemical changes consistent with α-synuclein fibrillation. Spectral shifts indicated decreased α-helical content with increased β-sheet structures. No consistent separation between DLB and PDD was observed. Conclusion This preliminary study demonstrates that combining Raman spectroscopy with machine learning can enable rapid, label-free detection of...
Proteomic Biomarkers and Diagnostic Tools in Ovarian Cancer: Understanding Their Clinical Value and Limitations
Publishing year: 2025
Journal article
Journal of Proteome Research, 2025, Volume 24, Issue 7
Scopus
Pages 3137-3153
Ovarian cancer (OC) is one of the most lethal gynecological cancers worldwide, with vague symptoms, an insidious onset, and high recurrence rates. With limitations in screening tests, OC is often diagnosed in late stages, resulting in high mortality rates and poor prognosis. To improve survival and quality of life for OC patients, there is an urgent need for effective biomarkers that can aid in early detection, treatment monitoring, and prognosis. Despite technological advancements, clinical applications remain limited and existing OC biomarkers often lack high sensitivity and specificity. As proteins are direct executors of biological processes, they are key to understanding the molecular and cellular mechanisms underlying pathological changes. Proteome-based biomarkers hold promise for improving OC diagnosis and management. Here, we review established and emerging technologies for identifying proteome-based biomarkers that, alone or in combination, could enhance OC diagnostics with a focus on future improvements. Single and multiple proteome biomarkers, including glycoproteome and peptidome-based ones, are assessed with respect to their sensitivity, specificity, and clinical utility for ovarian cancer diagnosis. Key diagnostic techniques are critically reviewed, including mass spectrometry-based methods for biomarker discovery, immunoassay-based approaches for biomarker validation and current clinical applications, and emerging technologies such as molecular Raman spectrosc...
P05. 05. A INTEGRATED MULTI-OMICS AND MULTI-SPECTRAL PROFILING OF PLASMA EXTRACELLULAR VESICLES REVEALS HIGHLY ACCURATE LIQUID BIOPSY BIOMARKERS FOR GLIOMA DIAGNOSIS.
Publishing year: 2025
Journal article
Neuro-Oncology 27 (Supplement_3), iii65-iii65, 2025, 2025, Volume 27, Issue Supplement_3
Google Scholar
Pages iii65-iii65
BACKGROUND
In glioblastoma (GBM) patients two factors are relevant for prediction of survival: MGMT promoter hypermethylation, which improves the patient’s response to temozolomide (TMZ), and the extent of resection (EOR), with a better overall survival (OS) described in patients subjected to gross total resection (GTR). The aim of our study is to analyze the level of concordance between the results obtained with the standard non-quantitative MGMT analysis methods compared to the quantitative real-time method EpiDirect® and to verify whether the different levels (frequencies) of MGMT promoter hypermethylation, assessed by EpiDirect®, can better predict the response to GBM treatment.
MATERIAL AND METHODS
MGMT promoter methylation in GBM IDH1 wt cases diagnosed from 2004 to 2022 in two neurosurgical centers (EOC and Insubria University Hospital, Italy …
Molecular Insights into α-Synuclein Fibrillation: A Raman Spectroscopy and Machine Learning Approach
Publishing year: 2025
Journal article
ACS Chemical Neuroscience, 2025, Volume 16, Issue 4
Scopus
Pages 687-698
The aggregation of α-synuclein is crucial to the development of Lewy body diseases, including Parkinson’s disease and dementia with Lewy bodies. The aggregation pathway of α-synuclein typically involves a defined sequence of nucleation, elongation, and secondary nucleation, exhibiting prion-like spreading. This study employed Raman spectroscopy and machine learning analysis, alongside complementary techniques, to characterize the biomolecular changes during the fibrillation of purified recombinant wild-type α-synuclein protein. Monomeric α-synuclein was produced, purified, and subjected to a 7-day fibrillation assay to generate preformed fibrils. Stages of α-synuclein fibrillation were analyzed using Raman spectroscopy, with aggregation confirmed through negative staining transmission electron microscopy, mass spectrometry, and light scattering analyses. A machine learning pipeline incorporating principal component analysis and uniform manifold approximation and projection was used to analyze the Raman spectral data and identify significant peaks, resulting in differentiation between sample groups. Notable spectral shifts in α-synuclein were found in various stages of aggregation. Early changes (D1) included increases in α-helical structures (1303, 1330 cm-1) and β-sheet formation (1045 cm-1), with reductions in COO- and CH2 bond regions (1406, 1445 cm-1). By D4, these structural shifts persist with additional β-sheet features. At D7, a decrease in β-sheet H-bonding (1625 cm-...
DEVELOPING AN EXTRACELLULAR VESICLE-BASED MULTI-OMIC LIQUID BIOPSY BIOMARKER SIGNATURE OF GLIOMA USING SAMPLES FROM THE GENOMICS ENGLAND BIOBANK
Publishing year: 2025
Journal article
Neuro-Oncology 27 (Supplement_2), ii9-ii10, 2025, 2025, Volume 27, Issue Supplement_2
Google Scholar
Pages ii9-ii10
ABSTRACT CITATION ID: NOAF185. 033 A SERVICE EVALUATION TO SCOPE THE EXPERIENCE OF PATIENTS AT WORKING AGE WHO ARE DIAGNOSED WITH GLIOMA.
79
Unique publications
46.8%
Open access (37 publications; 19 without information)
63.3%
With other institutions (50 publications; 19 without information)
H-Index Reports
| Index type | Scopus | Google Scholar | Web of Science |
|---|---|---|---|
| H-index | 23 | 26 | 1 |
| H5-index | 9 | 10 | 1 |
| H10-index | 15 | 16 | 1 |
Publications per year and source
No description yet.
- Faculty
- Faculty of Geotechnical Sciences and Environmental Management
- Department
- Department of Agricultural Sciences, Biotechnology and Food Science